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INTRODUCTION
1INTRODUCTION
Rheumatic Heart disease has been one of the major health problems in
developing countries like India. This is an autoimmune disease which occurs
in the cardiac tissues due to streptococcal throat infection. Pancarditis and
particularly vasculitis contributes the major complication following this
disease. Mitral valve constitutes about 50% of the valve which gets affected
due to rheumatic heart disease
The tricuspid value is situated at the base of the heart. It separates
right atrium from Right ventricle. It is defined as the Cinderella of cardiac
valves.
The tricuspid Annulus shortens during systole when the tricuspid valve
is competent.In left sided valve lesions( rheumatic heart diseases) right
ventricular dilataion occurs in association with pulmonary hypertension,the
tricuspid annulus also dilates and fails to shorten during systole. This Annular
dilatation results in failure of leaflet coaptation resulting in  tricuspid
regurgitation.
Tricuspid regurgitation is mostly overlooked or missed in the presence
of left sided valve lesion ,mild tricuspid regurgitation may get corrected after
correction of the left sided valve lesion but moderate and severe do not, My
study is to highlight the importance of addressing tricuspid valve
2concomitantly during mitral valve surgeries so as to improve the outcome and
avoid right ventricular failure.
The concept of functional tricuspid regurgitation getting corrected after
left sided valve pathology is corrected does not hold good for all cases of
tricuspid regurgitation especially moderate and severe tricuspid regurgitation.
Tricuspid regurgitation if dealt with early even before right ventricular
failure sets in has shown to give good results.so it is the early detection and
management of tricuspid regurgitation on the surgeons part which improves
the outcome.
About 200 cases of mitral valve replacement are done in Govt General
Hospital Chennai in a year ,hence to improve the outcome and to alleviate the
patient of symptoms of right ventricular failure and to avoid late tricuspid
regurgitation after mitral valve replacement, it is best to address all cases of
moderate /severe cases of functional tricuspid regurgitation secondary to left
sided valve lesions concomitantly during mitral valve surgeries.
This prospective study is to study the management of tricuspid
regurgitation in patients undergoing mitral valve replacement for rheumatic
mitral valve diseases.
AIM  OF  THE STUDY
3AIM OF THE STUDY
? To study the incidence of tricuspid regurgitation in rheumatic
mitral valve diseases patients undergoing mitral valve
replacement.
? To study the symptoms of tricuspid regurgitation.
? Evaluvation of tricuspid regurgitation.
? Management of tricuspid regurgitation in patients undergoing
mitral valve replacement for rheumatic mitral valve diseases.
REVIEW  OF  LITERATURE
4REVIEW OF LITERATURE
ANATOMY
Tricuspid valve has 3 leaftlets (1) Anterior (2) Posterior (3) Septal. The
septal leaflet is attached to the base of interventricular septum. The tricuspid
annulus is saddle shaped with its cantle to the mid point of the base of the
posterior leaflet and its pommel corresponding to the area of the
anteroseptalcommissure. The absence of encircling fibrotic structure explains
the large changes in tricuspid orifice during cardiac cycle and its early dilation
in disease.
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6In a canine model Tsakins1 and associates found that the size of this
tricuspid orifice changed continuously during cardiac cycle.
Changes in tricuspid annulus area Vertical lines indicate times of
measurement. The area of the tricuspid annulus is reduced during atrial and
ventricular contraction.
 The septal leaflet portion of the annulus does not lengthen much in thi
process because it is fixed between the right and left trigones and the atrial
and ventricular septa. The remaining two thirds of the annulus lengthens
greatly particularly that part giving origin to the posterior leaflet.
7The anterior leaflet is largest followed by the posterior leaflet and the
septal leaflet is the smallest.
The leaftlets are held down by the marginal and basal chords that arise
from three papillary muscles.
The Anteroseptal commissure is very close to the non coronary sinus of
the Aortic valve.
8The Right coronary artery runs parallel to the segment of the annulus
corresponding to the Right ventricular free wall.
The ostium of the coronary sinus is placed above the posterior
septalcommisure and is closely related to the bundle.
PATHOPHYSIOLOGY
Tricuspid Regurgitation has been classified into
 (1) Organic TR
 (2) Functional TR.
9In organic lesions the valve apparatus is macroscopically abnormal.
In Functional regurgitation there is only annular dilatation with normal
leaflets and subvalvular apparatus.
In autopsy study of patients with pure regurgitation waller et al 7
reported 47% of all tricuspid regurgitation were functional.
The total perimeter of the normal annulus is approximately 100-120mm
in case of functional TR  the circumference can reach 150-170mm.
Clinically the most common cause of annular dilatation is right
ventricular pressure overload secondary to rheumatic mitral valve disease.
Although surgery of left sided valve lesions can abolish functional TR it
cannot resolve the right ventricular dysfunction.
In CCF the presence of TR indicates poor outcome2
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DIAGNOSIS
Very little clinical criteria exist to determine the presence and degree of
tricuspid regurgitation .The absence of clinical signs does not exonerate the
surgeon from suspecting and treating it.
Chest X-Ray
TR regresses spontaneously after correction on left sided valve lesion
in some patients; other patients require re-operation only to repair a
previously ignored tricuspid valve.
Tricuspid symptoms are mostly extracardiac, it is mostly silent, the
patient only complains of asthenia.
ECG
The digital exploration of tricuspid valve through right atrium and to
decide upon the treatment based on regurgitation has been abandoned.
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Right heart catheterization and ventriculography has been superseded
by 2d colour Doppler echocardiography, as it is noninvasive and reliable.
In patients under general anaesthesia change on blood volume
secondary to diuretic administration,  vascular tone can reduce the degree of
TR.
Echo
Contrast echocardiography is a very reliable method for detection of TR
and the presence of PFO. It involves injecting saline with micro-bubbles in a
peripheral vein while observing the presence of air-bubbles in right atrium
during systole.3
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Since the tricuspid annulus is not circular it is difficult to get an exact
measurement of the diameter of tricuspid annulus. the tricuspid annulus is
saddle shaped.
Tricuspid annulus
The regression of TR after repair or replacement of left sided valve
lesion is unpredictable at best.
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TR SEVERITY AS DETERMINED BY ECHO MEASUREMENT OF ANNULAR
DIAMETER
A correlation exists between tricuspid annulus diameter and TR
severity. Normal tricuspid valve annulus diameter in adults is 28 mm (±5mm)
in the 4 chamber view. Significant tricuspid annular dilation is defined by a
diastolic diameter of 21 mm/square meter of body surface area (35 mm). A
systolic tricuspid diameter >3.2 cm or a diastolic tricuspid annulus diameter
>3.4 cm are often markers of more significant TR.
VENA CONTRACTA WIDTH MEASUREMENT OF TR
Severe TR is defined as vena contracta (the narrowest central flow
region of a jet that occurs at, or just downstream to, the orifice of a
regurgitant valve) width >0.7 .In case of multiple jets, the respective values of
the vena contracta width are not additive.
ECHO DOPPLER MEASUREMENT OF TR
An effective regurgitant orifice area greater than or equal to 40
mm/square meter of body surface area or a regurgitant volume of greater
than or equal to 45 ml indicates severe TR . Proximal isovelocity surface area
(PISA) radius 1 to 4 mm (mild), 5 to 8 mm (moderate), greater than 9 mm
(severe).. The PISA method may underestimate the severity of TR by 30%
and is also less accurate in eccentric jets.
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DOPPLER COLOUR FLOW JET MEASUREMENT OF TR
Colour flow imaging should only be used for diagnosing TR.  The colour
flow area of the regurgitant jet is not recommended to measure the severity of
TR.. A more quantitative approach is required when more than a small central
TR jet is observed.
INFERIOR VENA CAVA FLOW REVERSAL MEASUREMENT OF TR
The systolic hepatic flow reversal is specific for severe TR. It
represents the strongest additional parameter for evaluating the severity of
TR.
Echocardiographic and Doppler parameters
used in grading tricuspid regurgitation severity
Parameter Mild Moderate Severe
Tricuspid valve Usuallynormal
Normal or
abnormal
Abnormal/Flail
leaflet/Poor coaptation
RV/RA/IVC size Normal Normal ordilated Usually dilated
Jet area-central
jets (cm2) < 5 5-10 > 10
VC width (cm) Not defined Not defined, but< 0.7 > 0.7
PISA radius (cm) ? 0.5 0.6-0.9 > 0.9
Jet density and
contour–CW
Soft and
parabolic
Dense, variable
contour
Dense, triangular with
early peaking
Hepatic vein flow Systolicdominance
Systolic
blunting Systolic reversal
Severe lesions are usually treated but real or erroneously labeled
lesions are missed. The problem often lies in the absence of a detailed pre-
operative search for tricuspid disease.
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Initially it was believed that TR can resolve after diseased mitral valve
has been replaced, newer studies suggest that ignoring a diseased tricuspid
valve at the time of surgery for left sided pathology will interfere with the
eventful outcome of the patient.
Incidence of TR in MV disease: Tricuspid regurgitation is frequently
present in patients with MV disease with long standing pulmonary
hypertension.
Tricuspid regurgitation predicts poor outcome in all left sided valve
surgeries.
Patients with preoperative TR should have thier TR repaired during left
sided surgeries to prevent the progression of TR and avoid reoperations.
Groves et al.35 have shown that patients TR following mitral valve
replacement show decrease in oxygen consumption, exercise duration, and
anaerobic threshold compared with patients without tricuspid regurgitation
inspite of having good LV and prosthetic valve function.
Patients with TR have  reduced exercise capacity and fall  into  NYHA
class III or IV
 The normal TA is saddle-shaped, extending superiorly in an
anteroposterior orientation and inferiorly in a mediolateral orientation. With
the development of functional TR, the tricuspid annulus becomes dilated and
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more planar and circular 43. Antunes and Barlow 31 proved that rheumatic
process involving the tricuspid annulus weakens it.
The distance between the base of the septal and the base of the lateral
TV leaflets is taken as the normal tricuspid annulus diameter by
echocardiography in the 4- chamber view which  is 2.8 + 0.5 cm 41.
 TR resolved in patients with  chronic pulmonary hypertension because
of thrombus in the pulmonary artery pulmonary after endarterectomy was
done and in patients who had underwent balloon mitral valvotomy for mitral
valve diseases,but tricuspid annulus remained the same This shows that TA
dilation occurring as result of pulmonary hypertension did not reverse after
pulmonary hypertension has settled and this explains the mechanism of late
TR in mitral valve diseases.
Detailed history and physical signs are necessary to suggest significant
TR.
? Deep y descent on CVP
? Systolic murmur in the tricuspid area
? Pulsatile liver
? Pedal edema
? Elevated jugular venous pressure
? Elevated liver function test
? 2D echo
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Right-sided heart failure symptoms are peripheral edema, ascites,
congestive liver and spleen, pulsatile liver and pleural effusions. Patients with
TR have the presenting symptoms of reduced cardiac output which includes
fatigue and weakness .
          During inspiration, this finding is accentuated because of the
physiologic increase in venous return, which is called carvalo sign. The
cardiac auscultatory examination shows a third heart sound s3 which
increases with inspiration and decrease with Valsalva manoeuvre, P2 is loud
if pulmonary hypertension has developed, and a parasternal pansystolic
murmur is present which increases with inspiration.
           Impressive jugular venous distention with s wave or fused c and v
waves followed by a prominent y descent, is present in jugular venous
pressure.
 In the late stages, these patients are cachexic, cyanosed, and jaundiced.
Atrial fibrillation is common in these patients.
Cardiomegaly,right  atrial and right ventricular hypertrophy, a prominent
azygous vein, pleural effusion, and upward tenting of diaphragma owing to
ascites are seen in  chest x-ray.
The degree of regurgitation is assessed both preoperatively and
intraoperatively by echocardiography, structural abnormalities of the valve,
pulmonary artery pressures (PAPs), and right ventricular function can also be
obtained by echocardiography.
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The atrial septum is shifted to  the left and paradoxical septal motion is
present with right ventricular diastolic overload. Doppler and colourflow
studies help to identify systolic right ventricular to right atrial jet with inferior
vena cava and hepatic vein flow reversal.
Contrast enhanced echo which is obtained by injecting 5 ml of saline
injection into the right ventricle producing microcavities in right atrium that
are visible on echo, demonstrating to-and-fro motion across the valve orifice
and reversal into the inferior vena cava and hepatic veins. ASD or patent
foramen ovale should be ruled out.
          Echo can also show endocarditic lesions and vegetations, the valve
may be destroyed, and septic pulmonary embolus are a common feature. In
Carcinoid syndrome the valve leaflets are thickened and retractedand are in
semiopen position throughout the cardiac cycle.
Increased right atrial and right ventricular end-diastolic pressure are
demonstrated by cardiac catheterisation. the jugular venous pressure tracing
has an absent x descent, prominent v wave, and “ventricularization” of the
right atrial tracing,
Left sided lesions leading to secondary TR show increased pulmonary
artery pressures of over 60 mm Hg usually. (mitral and/or aortic) valve repair
or replacement is performed on arrested heart with antegrade/retrograde
cold cardioplegia, moderate systemic hypothermia by core cooling, and
topical cold saline surface cooling.
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Left atrium is opened through a left atrial incision posterior to the intra-
atrial septum or through a transseptalincision.The transseptal incision is
particularly useful when a prior aortic valve prosthesis is in place or in
reoperations.
In a reoperative setting, the tricuspid valve is approached through a
small right thoracotomy and has the advantage of avoiding adhesions and
possible injury to the right ventricle during repeat sternotomy.
After the cross clamp is removed and the heart picks up in sinus
rhythm, the tricuspid valve is addressed. During tricuspid valve suturing,
misplacement of a suture adversely affecting the bundle should be assessed
immediately and corrected.
 The Cox-Maze technique or ablation of atrial tissue using an energy
source like cryo can be added if atrial fibrillation is present.
Graves et al19 reported persistence of TR in 38% of patients with
isolated MVR.A widely cited report suggested that TR can resolve after
diseased mitral valve has been replaced.
King and colleagues reported 65% of patients returning for tricuspid
procedure late after mitral valve replacement, these patients had only mild TR
at the time of initial operation.17
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Management of TR in MV disease.
Mild tricuspid regurgitation is managed conservatively with diuretics
and aldosterone antagonist to bring down the fluid overload and to decrease
hepatic and splanchnic congestion.liver function test has to be continuosly
monitored and followed.
Late TR in mitral valve diseases can lead to reoperations  for tricuspid
valve  if moderate TR is ignored during  mitral valve surgery.
Tricuspid valve is amenable to repair and hence considering the
complications  of prosthetic valve repair is better than valve replacement.
There are different varities of prosthetic valve available in the market.
Prosthetic valves need anticoagulation where as bioprosthetic  valves
do not need anticoagulation but they tend to degenerate with time.
 Tang et al showed in their study tricuspid valve repair with an
annuloplasty ring resulted in significant improvement and long-term survival a
free of recurrent TR compared with De Vega suture annuloplasty. 47 In severe
organic TR Tricuspid valve is not repairable and hence it as to be replaced.
modified De Vega repair with pledgeted sutures in patients with
functional tricuspid regurgitation has had good results in the hands of
experienced surgeons.
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 McCarthy et al. 48 assesed the durability of TV repair which showed
ring annuloplasty repair was better than devega repair.
 Dreyfus et al.27 showed the utility of TV ring annuloplasty during MV
surgery and the importance of tricuspid annulus/diameter as a criterion for TV
repair They studied patients undergoing MV repair (65% degenerative and
only 14% rheumatic MV disease). The TV annulus diameter was measured
intraoperatively with a scale from the anteroposterior commissure.  to the
anteroseptal commissure. They used Carpentier-Edwards ring  for all cases
of tricuspid regurgitation with dilated annulus was 7 cm in diamter (equivalent
to 4 cm by echocardiography).
These results show that the tricuspid annulus diameter limit for repair
should have been set lower, somewhere between 3.0 and 4.0 cm. It is best to
set  the normal TA at 3.0 cm. a limit of 2.1 cm/m2 (equivalent to 3.6 cm for an
average person)as suggested by Groves et al. 19. They relied on a study by
Chopra et al, who found this diameter to best differentiate severe from
nonsevere TR. The threshold should be lower with increasing degrees of TR
and in rheumatic patients.
22
Tricuspid annular dilatation
 Prospective, randomized trials are needed to get a better idea of this
cutoff point. On the basis of the available information and personal
experience, it is believed that prophylactic tricuspid valve repair should be
performed in patients undergoing MVR regardless of TR severity whenever
the TV annulus is >3.5 cm, especially in rheumatic TR.
  Early on, when patients presented only with few symptoms, the high-
risk of surgery was not taken seriously. Later, when symptoms demand
surgery, RV dysfunction has already set in and is irreversible.
Treatment of patients who develop late isolated TR after MVR is
difficult and mainly conservative for mild tricuspid regurgitation. Antifailure
therapy with loop diuretic drugs and aldosterone antagonist are the mainstay
of therapy and might delay TR progression. In some patients in whom surgery
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is not an option, chronic dialysis is  useful, in treating volume overload and
improving quality of life. Right ventricular function is very difficult  to estimate
by echocardiography.
Tissue Doppler imaging is useful in identifying patients with preserved
RV function (tricuspid systolic annular velocity _9.5 cm/s). Right ventricular
function is assessed by newer techniques such as 3-dimensional
echocardiography and Doppler study such as the RV myocardial performance
index (MPI) and isovolumic acceleration index (IVA), magnetic resonance
imaging might prove useful in the future and might help to find the ideal
timing of surgery so as to avoid RV dysfunction which can be irreversible.
Kay et al showed satisfactory results after bicuspidization.18 Barratt and
boyes in chapter 11 suggest that TR progresses if the primary left sided valve
disease progresses. Carpentier  et al found no TR   postoperatively in 68% of
patients with preoperative moderate to severe TR after concomitant tricuspid
valve surgery.19
CarpentierRing
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Reoperation after carpentier ring annuloplasty is not necessary as
proved by a 3 year follow up. Nikano et al reported after suture annuloplasty
94% patients were free of reoperation 10 years later.20
Goldman et al injected 5ml of dns or saline into right ventricle to
generate echogenic contrast. TR was quantified for a scale of 0-4+ based on
eyeballing.
Carlos M.G.Duran et al have suggested 27mm/m2 as the critical
diameter above which functional TR always appeared. Goldman et al have
suggested 30mm as the cut off point between absent/mild TR and moderate
/severe TR.
Cosgrove annuloplasty
First closed tricuspid commisurotomy was done  in 1952 by Charles
bailey6. Wooler et  al99/kay et al7 did the earliest of annuloplasties at the level
of the base of posterior leaflet. Extendedtransatrialseptal incision was
described by guiraudon et al.5
Cabrol12 and devega22 independently described encircling suture to
narrow annulus running along the base of anterior and posterior leaflets
anchored in anteroseptal and posteroseptalcommisures.
25
Kay’s Procedure
Kay annuloplasty basically involves plication of the annulus in the
region of the posterior leaflet . This narrows the annulus and basically
obliterates the posterior leaflet of the tricuspid valve
The Devega annuloplasty is a tricuspid repair in which two limbs of a
pledgetted stitch are brought around the annulus of the septal and anterior
leaflet. The stitch is tightened such that only two gloved fingers may be
passed through the tricuspid orifice. The conduction tissue adjacent to the
septal annulus is totally avoided.
26
DEVEGA REPAIR
Certainly patients undergoing second mitral valve operations with
associated 2+ or greater tricuspid TR, patients with long-standing left atrial
hypertension, typically rheumatic patients with 2+ or greater TR, and anyone
likely to have persistent pulmonary hypertension and 2+ or greater TR should
be strongly considered for concomitant tricuspid repair as part of their
planned cardiac procedure.
Tricuspid valve repair in carefully selected patients may improve
forward flow and improve the marked venous congestion that these patients
suffer.
In the rare patient with isolated tricuspid insufficiency, surgical
correction is warranted when symptoms are refractory to maximal medical
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therapy. Often these patients will have difficult-to-treat congestive heart
failure with significant peripheral edema and clinically significant passive
congestion of the liver. Intensified diuretic administration often results in rise
in blood urea nitrogen (BUN) and creatinine rather than improvement in the
patient's clinical status.
In considering repair of the tricuspid valve, the DeVegaannuloplasty
technique is used not frequently. This technique would be considered in
cases that tricuspid regurgitation is secondary to a left-sided process and the
amount of tricuspid regurgitation is 2+ or less by echocardiography with
colour flow Doppler.
For the DeVegaannuloplasty , 3-0 Prolene double-arm pledgeted
sutures are used. The inner suture line is begun approximately 3 mm off of
the tricuspid annulus. The bites are approximately 3 mm in depth and 5 mm
in length, skipping 5 mm between bites. This inner suture line proceeds in a
clockwise fashion around the annulus to the posteroseptal commissure. The
outer suture line is 3 mm outside the first and is placed in a similar fashion, in
a clockwise direction to the posteroseptal commissure. A second Teflon
pledget is passed onto the free ends of the suture. The suture is tightened
down over a tricuspid ring sizer. A No. 29 sizer is generally adequate.
The overwhelming majority of tricuspid valves are repaired. The basic
techniques for repair include bicuspidization, annular plication and various
types of annuloplasty, i.e., ring annuloplasty, linear reduction annuloplasty,
and so-called suture annuloplasty. The most common repair is likely the
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DeVega suture annuloplasty in which a continuous monofilament prolene
suture is run from the base of the junction of the septal leaflet, pledged on
each end circumferentially, and the annulus is reduced. The ring-type
annuloplasty places a ring structure into the non-septal portion of the
tricuspid valve annulus. Another technique is called a multi-pledget
technique, which was very much like the DeVega technique except instead of
a single set of pledgets at either end,  the same suture was ran through
multiple pledgets to keep it from cutting though the fragile annular tissue.
 In isolated tricuspid regurgitation and for more severe forms of
regurgitation with annular dilation in the presence of structurally normal
leaflets, tricuspid ring annuloplasty is performed. Carpentier-Edwards
tricuspid annuloplasty ring is used, which is an incomplete ring leaving a gap
in the area of  septal annulus adjacent to the conduction system. Sizing of the
annuloplasty ring is done by measuring the intercommissural distance
(anterior leaflet length). This can be done most accurately by distracting the
chordae of the anterior leaflet adjacent to the commissures while using the
ring sizers. Typically a No. 33 ring will be used for male patients and a No. 31
ring will be used for female patients.
Horizontal mattress sutures consisting of 2-0 ethibond with pledgets
are used. No preset number of sutures is used for every case; rather a
number suited to each particular patient is used. Typically there will be 3 mm
to 4 mm between each suture in the annulus and 1 mm to 2 mm of space
between each suture as it is placed through the annuloplasty ring. This will
ensure even distribution of the annular plication around the circumference of
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the annuloplasty band. Each stitch enters the atrial tissue just outside the
annulus and exits within the annulus . The suture is then placed through the
inside of the ring to get the ring to sit in a directly annular position. The ring is
lowered down to its annular position, and the sutures are tied and cut .
30
Carpentier ringannuloplasty
31
Carpenter rigid prosthetic ring open at anteroseptalcommisure to avoid
the conducting system.13
Kaplan et al advocated bileaflet prosthesis.52Matsuyama et al reported
significant TR on echo postoperatively in patients who underwent MVR with
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grade 2+TR.Tricuspid annuloplasty with a ring should be performed at the
time of initial mitral valve surgery. Tricuspid annulus diameter is the best
criteria for performing annuloplasty.
31Antunes and barlow suggested that rheumatic disease directly
involves  the tricuspid annulus and weakens the annulus and causes it to
dilate.
Sugimoto et al showed a good correlation between tricuspid diameter
and tricuspid regurgitant volume.
Patients who have concomitant successful maze procedure during their
MVR were reported to have less TR,which has been proved by Kim HK, Kim
YJ in impact of maze operation with Left valve surgery.
25Tricuspid valve repair with annuloplasty ring resulted in long term
survival free of recurrent TR in a study by Tang et al.
28Chopra et al found that diameter was best to differentiate severe from
non severe TR.
   Preoperative and intraoperative echocardiograms are valuable
assessment tools to help the surgeon understand the structure and
function of the valve.
The old technique of keeping a finger into the right atrium by taking a
purse string in the right atrium to palpate the tricuspid valve and keeping the
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fingertip 2 to 3 cm from the valve orifice to access the force of the regurgitant
jet is not important now.
The tricuspid annulus is a component of both the tricuspid valve and
the right ventricle. the tricuspid valve leaks if the tricuspid annulus and  the
right ventricle are dilated. There is a very low probability for TR  If the
tricuspid annulus and the right ventricle are not dilated, tricuspid annulus
dilates in the anterior and posterior directions and corresponds to the free
wall of the right ventricle.
The grade of pulmonary hypertension, right ventricular dilatation, and
systolic function, coupled with the size of the right atrium, must be taken into
account for decision making. The intra operative transesophageal
echocardiogram (TEE) shows the surgeon the tricuspid regurgitation and
reversal of flow in the inferior cava. Good TEE assessment after the repair is
necessary in completing a good and satisfactory repair.
It is important to understand  these important fundamental facts for
current practice regarding the management of functional TR, which focuses
on assessment of the severity of TR and advocates treatment of tricuspid
regurgitation along with the primary one  (i.e., mitral valve replacement).
Treatment of the mitral valve lesion alone only decreases the afterload. It
neither brings down the preload nor correct tricuspid dilatation, nor does it
improve right ventricular function. Once the tricuspid annulus is dilated, it
does not  return to normal spontaneously, and it may in fact, continue to
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progress further. This explains why some patients come for a second
operation for TR years after the initial mitral valve surgery.
The degree of TR is also directly related to three important factors. In
addition to the preload, the afterload, tricuspid dilatation, and right ventricular
function.TR is difficult to assess accurately as these three factors can
interfere with the severity of TR under different conditions and are variable.
Significant TR may not be detected echocardiographically despite
considerable annular dilatation in the tricuspid valve in these situations.
MITRAL VALVE REPLACEMENT
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DEVEGA TECHNIQUE
A 3-0 prolene/2-0 prolene suture is started at the junction of the
annulus and right venyricular wall and is continued from the anteroseptal
commisure to the posteroseptal commisure. The other arm of the suture is
placed through a pledget and is run parallel and close to the first suture line
in the same clockwise direction, placing it through a second pledget at the
posteroseptal commissure.
A purse-string effect is produced on tightening the suture and reduces
the length of the anterior and posterior annulus to provide adequate leaflet
coaptation and orifice flow . The DeVega technique is also employed for mild
to moderate annular dilatation.
The annuloplasty provides a competent tricuspid valve during the early
post operative course, while the remodeling of the heart after surgical
treatment of the left-sided valvular lesions takes some time
.
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DEVEGA REPAIR
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BICUSPIDIZATION
The SVC and IVC are snared the right atrium is opened by an oblique
incision. Good exposure of the tricuspid valve is a basic requirement for
tricuspid repair.
The pledgeted mattress sutures are taken from the center of the
posterior leaflet to the commissure between the septal and posterior leaflets.
A second suture should be done to further reduce the annulus, ensuring good
leaflet coaptation while providing  adequate orifice for flow. An annuloplasty
ring need to be inserted after the repair to further support the annular
reduction if needed.
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BICUSPIDIZATION
RINGS AND BANDS
There are various types of rings ,rigid rings and flexible rings
 Carpentier- Edwards and MC3
 flexible rings (e.g., Duran)
 flexiblebands (e.g., Cosgrove annuloplasty system).
 The intertrigonal distance or the length of the base of the septal leaflet
is taken to determine the size of the ring or band. These devices avoid suture
placement in the region of the atrioventricular (AV) node (apex of the triangle
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of Koch) to avoid injury to the bundle. The mattress sutures are placed in a
circular fashion, taking widely on the annulus and small corresponding bites
through the skirt of the ring or band, which produces annular cooptation along
the length of the posterior leaflet. This allows the tricuspid valve orifice to be
occluded by the leaflet tissue of the anterior and septal leaflets.
CARPENTIER RING ANNULOPLASTY
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CARPENTIER RING ANNULOPLASTY
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TRICUSPID VALVE REPLACEMENT
The prosthetic tricuspid valve is fixed with pledgetted mattress sutures
using an horizontal everting sutures either a supra-annular or an intra-annular
technique for prosthetic valves. The tricuspid valve leaflets are left
undisturbed, preserving the subvalvular structures and avoiding injury to the
bundle. If there is concern that the anterior leaflet could fold and thereby
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obstructing the right ventricular outflow tract, only the central portion of the
leaflet can be excised preserving the subvalvular apparatus.
A mitral homograft can be used to replace tricuspid valve. The
homograft tissue is usually a mitral valve. The intratrigonal distance is
measured. The papillary muscles are fixed through the wall of the right
ventricle. The chordal length needs to be adjusted. The annulus is sutured
with a 3-o prolene. A ring annuloplasty  is done to prevent dilatation and to
ensure adequate leaflet cooptation. Care is taken to avoid the bundle.
MC3 TRICUSPID VALVE ANNULOPLASTY
A new tricuspid valve (TV) annuloplasty system, the MC3 ring, is a
three-dimensional structure designed to remodel the TV annulus and
preserve physiologic annular function.
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The MC3 TV annuloplasty ring is the first TV annuloplasty ring
anatomically designed to conform to the three-dimensional shape of the
normal TV and minimize stress on sutures. Progressive flexibility is created
from the unique processing of the titanium band. The Edwards MC3
annuloplasty ring is covered with material that favours host tissue ingrowth
In endocarditis a stentless porcine valve or equine valve is used in
which the commissural posts were anchored to the right ventricular septal,
anterior, and posterior walls. Orientation is important so that the right
ventricular outflow tract is straddled by two of the commissural posts and
does not obstruct it.
Carpentier techniques for MVR can be applied to the organic tricuspid
valve. Leaflet tears due to trauma, healed granulomas and perforations due
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to endocarditis, or the rare myxomatous valve can be repaired. Pericardial
patch closure of perforations, limited resections including triangular and
quadrangular  resections of the anterior (limited) or posterior (extensive)
leaflets, and ring annuloplasty are routinely done techniques to produce
competent valves and avoid replacement.
  TV annulus should be assessed in all mitral valve surgeries and
annuloplasty should be considered. Aggressive repair of accompanying TR
should be taken at the time of MVR with large atrium or AF even if pre
operative TR is 2+.
McCarthy et al  has studied  the durability of tricuspid valve repair.
Study  by  Dreyfus  et  al  gives  the  best  evidence  for  the  utility   of   TV  ring
annuloplasty during MV surgery and the importance  of TA diameter as a
criterion for TV repair.
On the basis of the available information ,Prophylactic TV repair should
be performed in patients undergoing MVR regardless of the grade of TR if the
TV annulus is >3.5 cm, especially in rheumatic patients.
TV assessment, including measurement of the TA diameter, is
mandatory in patients with MV disease. It is better to do Mitral valve surgery
or balloon valvotomy before RV dysfunction and severe TR sets in.
 A TV ring annuloplasty is the best procedure to correct or prevent TR
in most cases. It improves the outcome, prevents late TR and heart failure,
and therefore shuld be performed at the time of the initial mitral valve
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surgery. The TA diameter is the best guide to select patients for TV repair,
and the echocardiographic limit should be 3.5 cm regardless of TR severity
and can be lower for rheumatic patients.old Patients with significant TR who
have longstanding MV disease,and those who are in AF, long standing
nonsevere pulmonary hypertension, large left atrium and organic TV disease
will benefit more from MV surgery with TV repair/replacement.
PATIENTS AND METHODS
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PATIENTS AND METHODS
This prospective study was under taken as an observational evaluation
of Management of tricuspid regurgitation in patients undergoing mitral valve
replacement for rheumatic mitral valve diseases among the newly registered
patients undergoing mitral valve replacement in Department of Cardio
Thoracic Surgery at Government General Hospital, Chennai, using a
descriptive method of analysis over a period of 30 months from August 2009 to
February 2012.
INCLUSION CRITERIA
Patients undergoing mitral valve replacement for rheumatic mitral valve
diseases
Age group 20-40years
EXLCUSION CRITERIA
? Patients with mitral restenosis
? Age >40
? Patients with combined other valvular heart diseases
? Congenital tricuspid regurgitation
? Tricuspid regurgitation due to other causes
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METHODOLOGY
Information regarding each patient is entered in a proforma specially
designed to include all relevant information.
Detailed history is recorded using pre framed questionnaires.
A through physical examination consisting of general examination,
cardiovascular, respiratory and other physical findings are done and
recorded.
Trans-thoracic ECHO cardio graphic evaluation is done pre operatively
and post operatively
TEE is done for special cases.
PREOPERATIVE EVALUATION
All patients were examined by both the cardiologist and the cardiac
surgeon before they were enrolled in the study. The patients underwent full
clinical evaluation, including routine laboratory tests (erythrocyte
sedimentation rate, antistreptolysin-0 titer, and C-reactive protein, liver
function test), and radiologic and electrocardiographic examination.
Preoperative and postoperative echo was done and tricuspid
regurgitation graded according to
1) Proximal Isovelocity Surface Area(PISA).
2) Echo doppler
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3) Vena contracta
4) Colour Doppler
PRE-OP PROCEDURE
Patients were given pre-op antibiotics and anaesthesia induced in
supine position. Pre-op CVP noted before inducing anaesthesia.
OPERATIVE PROCEDURE
Patient in supine position, median sternotomy, systemic heparinization,
aorta cannulated, bicaval venous cannulation done, cardio pulmonary bypass
established core cooled to 280celcius, aorta cross clamped,root cold
cardioplegia given heart arrested in diastole, left atrium opened diseased
mitral valve excised prosthetic mitral valve replaced with everting mattress 2-
0 ethibond sutures ,left atrium closed with 4-0 prolene, core rewarmed, cross
clamp released, heart picked up in sinus rhythm, SVC and IVC were snugged
right atrium opened parallel to sondegrads groove tricuspid valve assessed
and the necessary procedure devega/annuloplasty done.
DEVEGA
Horizontal cotinuous sutures are taken parallel to anterior and posterior
leaflets only avoiding the septal leaflet so as to not to injure the bundle and
tied.
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ANNULOPLASTY
Classic carpentier ring was introduced by horizontal mattress
interrupted sutures
Right atrium closed with 4-0 prolene
Gradually weaned off cardiopulmonary bypass ,decannulation done
heparin neutralised with protamine ,complete hemostasis secured ,right
pleuro pericardial drain kept stenotomy closed with wires, wound closed in
layers.
POST OP PERIOD
The patient was extubated in the POST OP ICU after 6 hours of
elective ventilation and   Twenty-four hours later, the intercostal tube was
removed and the patient was discharged from intermediate care.the patients
are followed up with tablet acitrome(acecoumarin) with an INR of 2.5-3.0.
After recovery follow-up echocardiography was performed with
particular attention to checking for tricuspid regurgitation
ETHICS
Ethical committee clearance was obtained and all the procedures
followed in accordance with the ethical standards. Photographs were taken
with patient and their relative’s full consent.
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GLOSSARY
TV-tricupid valve
TA-tricuspid annulus
MVR-mitral valve replacement
TR-tricuspid regurgitation
RHF-right heart failure
JVP – Jugular Venous pressure
PE  - Pedal Edema
LFT- liver fuction test
CAMS- calcific mitral stenosis
MS/MR-mitral stenosis/mitral regurgitation
OBSERVATION
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OBSERVATION
Total Number of cases: 250
PARAMETERS STUDIED
? Personal details
? Symptoms
? Signs
? Echo
? Surgery
? Complications
? Management of TRICUSPID  regurgitation
All the above details were analyzed and tabulated in the masterwork
sheet and statistic significance arrived.
In my study of 250 patients, patients with moderate/severe tricuspid
regurgitation underwent tricuspid repair (annuloplasty/ devega) concomitantly
during mitral valve replacement which significantly decreased post op
tricuspid regurgitation, which left alone would have made the prognosis bad.
All post op patients had no symptoms of right heart failure.
They were followed for a period of 6 months to 1 year with a minimum
of 3 visits.
In my study I observed a significant change in patients who underwent
tricuspid repair for moderate and severe regurgitation concomitantly with
mitral valve replacement.
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AGE AND SEX DISTRIBUTION
Table -1
GENDER Frequency Percent
Male 107 42.8
Female 143 57.2
Total 250 100.0
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90 patients were in the age group of 20-30 and 160 of them were in the age
group of 30-40.males comprised 42.8%, females comprised 57.2%.This
showed a definite female predeliction as rheumatic mitral valve disease is
more common in females. This clearly shows tricuspid regurgitation is more
seen in patients with long standing left side valve lesions associated with
pulmonary hypertension.
Table -2
Age Group Frequency Percent
20 - 30 yrs 90 36.0
31 - 40 yrs 160 64.0
Total 250 100.0
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Distribution of tricuspid regurgitation in mitral valve diseases
Calcific mitral stenosis patients had 28.8% TR
Mitral stenosis/ mitralregurgitation patients had 38.4% TR
Mitral stenosis /left atrial clot patients had 20% TR
Mitral regurgitation (severe) patients had 12.8% TR
Tricuspid regurgitation is more common in mitralstenosis/mitral regurgitation
associated with long standing pulmonary hypertension.
Table -3
Diagnosis Frequency Percent
CAMS 72 28.8
MS / MR 96 38.4
MS / LA clot 50 20.0
MR (severe) 32 12.8
Total 250 100.0
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SYMPTOMS AND SIGNS
The symptoms and signs including pedal edema ,raised jugular venous
pressure, raised liver fuction test were more in severe TR and less in
moderate TR followed by mild TR.
Symptoms
Pre OP  TR
Mild Moderate Severe
PE 40 60 80.0
JVP 20 30 40.0
LFT 8 10 17.0
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TRICUSPID REGURGITATION AND ITS TREATMENT
37 patients with mild regurgitation were  managed conservatively with
diuretics .Annuloplasty was done for 95 patients with moderate and severe
regurgitation ,devega was done in 118 patients with moderate and severe
regurgitation. Tricuspid valve replacement was not done .
Hence tricuspid repair in mvr patients showed a significant decrease in
tricuspid regurgitation.
PROCEDURE Frequency Percent
MVR 37 14.8
MVR / Ring Annuloplasty 95 38.0
MVR / DevegaRepair 118 47.2
Total 250 100.0
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PREOP TRICUSPID REGURGITATION
Mild tricuspid regurgitation was present in 13.6% of patients .moderate
tricuspid regurgitation was present in 52.8% of patients. Severe tricuspid
regurgitation was present in 33.6% of patients. this study shows majority of
patients with moderate tricuspid regurgitation,since ours being a tertiary
centre tricuspid regurgitation is diagnosed even at the early stage.
PRE OP TR Frequency Percent
Mild 34 13.6
Moderate 132 52.8
Severe 84 33.6
Total 250 100.0
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POST OP TRICUSPID REGURGITATION
Post operatively 97.2% of patients had mild tricupid regurgitation.moderate
tricuspid regurgitation persisted in 7 patients 2.8%.tricuspid repair was not
done in 3 cases with moderate TR and in 4 cases the tricuspid repair done
failed to bring down moderate TR.This was managed conservatively without
redo surgeries.
Table -6
POST OP TR Frequency Percent
Mild 243 97.2
Moderate 7 2.8
Total 250 100.0
61
OUTCOME
As majority of my patient were in the group of moderate tricuspid
regurgitation 52.4% followed by sever tricuspid regurgitation 33.6%and mild
regurgitation 14%.the mild group was managed with MVR alone and diuretics.
The moderate  and severe group showed an improvement in post operative
TR by 84.4%.
All the patients are followed for a period of 6 months, patients with mild
TR had a definite decrease in the right heart failure symptoms and they are
followed up with diuretics.
Two  patients who underwent mitral valve replacement alone with
moderate tricuspid regurgitation died two years after surgery due to low
cardiac output failure.Two patients who underwent MVR+TVR died two years
after surgery due to struck valve and bleeding complications rrespectively.
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Improvement Frequency Percent
Improved 211 84.4
Static 39 15.6
Total 250 100.0
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Total 37 100.0 213 100.0 250 100.0
DISCUSSION
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DISCUSSION
In the current study we have selected only a small group of patients
and have excluded all the complicated cases. This study shows a definite
predeliction of moderate and severe TR in patients presenting in their third
decade of life and more in female population which can be associated with
long standing pulmonary hypertension. Patients with mitral stenosis/mitral
regurgitation in atrial fibrillation and huge left atrium tend to develop early
pulmonary hypertension and subsequent TR when compared to other groups
of patients undergoing mitral valve replacement.
A study by katushiko Matsuyama56 et al concluded that Aggressive
repair of accompanying TR should be undertaken at the time of initial surgery
in patients with huge left atrium or atrial fibrillation, even if preoperative TR is
2+.
        In a study by alex sagie53 et al study of  patients undergoing bollon
mitral valvotomy for mitralvalvestenosis,he observed severe TR to be present
in all cases of severe and long standing mitral stenosis and these patients
have advanced mitral valve and pulmonary vascular diseases followed by
poor outcome.
Postoperative TR has consistently come down in all patients
undergoing tricuspid valve repair irrespsctive of the preoperative diagnosis
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for which MVR was planned concomitantly with mitral valve replacement as
has been demonstrated by other studies also.
In a study by kenjikuwaki et al54 to prevent late tricuspid reoperation
after mitral valve surgery it is best to not to leave residual TR of grade more
than 2+. It would be better if tricuspid valve surgery is done concomitantly
with mitral valve surgery.
The present study shows a definite reduction in tricuspid regurgitation if
tricuspid repair has been done along  with MVR. Statistical significance of my
study is <0.001  which is comparable with other studies.
In a study by gilles drefyus55 tricuspid  annulus remodelling improves
the functional  state. Tricuspid dilatation is an ongoing   process that will with
time may progress if not treated.
Tricuspid regurgitation has significantly improved in patients who
underwent TVR with MVR as shown by their immediate post operative
echocardiogram and the mild TR patients in whom MVR alone was done also
showed an improvement in their symptoms in their subsequent follow ups.
Of the 250 patients who underwent mitral valve replacement, tricuspid
repair was not done in  three cases with moderate TR. Their post operative
echo showed moderate TR ,which was conservatively managed and followed
up. four patients who underwent tricuspid repair still persisted with moderate
TR and they are managed conservatively.
SUMMARY
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SUMMARY
This prospective observational study reflects the epidemiological
pattern of tricuspid regurgitation in patients presenting in GOVT GEN
HOSPITAL CHENNAI during the period of AUG2009-FEB2012 for mitral valve
replacement,and the management of tricuspid regurgitation in patients
undergoing  MVR for rheumatic mitral valve diseases and its outcome.
? Tricuspid regurgitation has a definite predilection towards female sex
and third decade of life.
? Tricuspid regurgitation is more seen in patients with severe MS/MR
with huge left atrium and in patients in atrial fibrillation with long
standing pulmonary hypertension.
? Patients who present for mitral valve replacement mostly have
moderate TR followed by severe TR and only few 13.6% presented
with mild TR.
? Symptoms and signs of TR were obviously more in the severe TR
group followed by the moderate TR and mild TR.
? Devega repair was done in 47.2% of patients,Ringannuloplasty was
done in 38% of patients,and MVR alone was done in 14.8% of
patients with moderate and severe TR.
? The postoperative TR was decreased in 97.2% of patients, who
underwent TVR with MVR.
? In this study 84.4% of patients showed an improvement in symptoms of
signs of TR post operatively.
CONCLUSION
67
CONCLUSION
This study shows that long standing mitral valve lesions demanding
mitral valve replacement are associated with pulmonary hypertension and
tricuspid annular dilatation leading onto varying grades of functional tricuspid
regurgitation.
This study also emphasises on the point of not overlooking or
neglecting tricuspid valve in cases of rheumatic mitral valve diseases with
tricuspid regurgitation. Mild tricuspid regurgitation can be managed with MVR
alone and conservatively but Moderate and Severe tricuspid regurgitation
definitely needs addressing of the tricuspid valve by repair to improve the
outcome and prevent both morbidity and mortality.
This study shows that moderate and severe functional tricuspid
regurgitation addressed either by devega or ring annuloplasty concomitantly
during mitral valve replacement has significantly brought down the post
operative tricuspid regurgitation and hence improves the outcome.
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ANNEXURES
THESIS PROFORMA FOR M.Ch CARDIO VASCULAR AND
THORACIC SURGERY
DISSERTATION ON
A STUDY ON MANAGEMENT OF TRICUSPID REGURGITATION IN PATIENTS
UNDERGOING MITRAL VALVE REPLACEMENT  FOR RHEUMATIC MITRAL
VALVE DISEASES
Patient Profile
SL NO:
Name : DOA:
DOD:
DOS:
Age :
Sex :
IP No :
ADDRESS :
SOCIOECONOMICAL STATUS :
? Working    /    Dependent :
? Monthly Earning :
? Religion :
? Educational Status :
FINAL DIAGNOSIS
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UNDERGOING MITRAL VALVE REPLACEMENT  FOR RHEUMATIC MITRAL
VALVE DISEASES
History
Presenting Complaints : PEDAL EDEMA
ANGINA:
BREATHLESSNESS:
PALPITATION:
HEMOPTYSIS:
OTHERS:
Past History :
RHEUMATIC FEVER:
H/O SURGERY:
OTHERS:
Personal History :
Family History :
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Examination
General Examination:
Systemic Examination:
Cardiovascular:
Respiratory:
Abdomen:
Central Nervous:
Skull & Spine:
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VALVE DISEASES
Investigations
Heamatogram:
Biochemical Profile:
Radiogram:
Chest X-ray:
Echo Cardiogram:
Others:
Mitral Valve Status:
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Operative History
Preoperative Status:
Operation Notes:
Per operative Findings:
PICTURES ATTACHED: YES / NO
 NUMBERS:
Postoperative Period:
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Post OP Complications & Management
Follow up:
             NAME  AGE  SEX IP NUMBER  DIAGNOSIS   PROCEDURE   PREOP TR POST OP TR
1 SANGEETHA 24 FEMALE 42805  CA/ MS MVR/DEVEGA  MILD MILD
2 MAHESWARI 32 FEMALE 40416  MS/MR MVR/DEVEGA MOD MILD
3 NARAYANAN 30 MALE 42481   MS/MR MVR/DEVEGA MOD MILD
4 DIWAKAR 20 MALE 39745  MR(SEVERE) MVR/DEVEGA  MOD MILD
5 PUSHPARANI 33 FEMALE 51623 MS/LA CLOT  MVR/DEVEGA MOD  MILD
6 MALATHY 28 FEMALE 51592  CA/ MS MVR/DEVEGA MILD  MILD
7 EGAVALLI 30 FEMALE 48807  CA/ MS MVR/DEVEGA MOD MOD
8 ADAIKALAM 38 MALE 42918  CA/ MS MVR/ANNULOPLASTY MOD MILD
9 KANNIAMMAL 40 FEMALE 51459 CA/MS MVR/DEVEGA MOD MILD
10 MEENAKSHI 40 FEMALE 40509 MS/LACLOT MVR MILD MILD
11 SHANMUGHAM 35 MALE 37667 MS/MR MVR/ANNULOPLASTY MOD MILD
12 ARUMUGAM 25 MALE 39746 MR(SEVERE) MVR/DEVEGA MOD MILD
13 MANTHIRAKUMAR 40 MALE 53394 CAMS MVR/DEVEGA MOD MILD
14 VIGNESH 24 MALE 56563 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
15 SANGEETHA 22 FEMALE 56575 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
16 LAXMI 30 FEMALE 52439 CAMS MVR/ANNULOPLASTY SEVERE MILD
17 CHANDRAN 35 MALE 49737 MS/MR MVR/ANNULOPLASTY SEVERE MILD
18 AMUDHA 21 FEMALE 52427 MR(SEVERE) MVR/DEVEGA MOD MILD
19 FAQRUDEEN 38 MALE 54287 CAMS MVR MILD MILD
20 SALIM 21 MALE 26600 MR(SEVERE) MVR/DEVEGA MOD MILD
21 SHANKAR 40 MALE 45590 CAMS MVR/DEVEGA MOD MILD
22 VINNARASI 20 FEMALE 52482 MR(SEVERE) MVR/DEVEGA MOD MILD
23 SIVAKUMAR 30 MALE 39753 MS/MR MVR/DEVEGA MOD MILD
24 MARIMUTHU 40 MALE 53716 CAMS MVR/DEVEGA MOD MILD
25 SEKHAR 38 MALE 60583 MS/MR MVR/DEVEGA MOD MILD
26 SATISH 40 MALE 60903 CAMS MVR/ANNULOPLASTY SEVERE MILD
27 TAMILARASI 40 FEMALE 58015 CAMS MVR MILD MILD
28 VIJAYALAXMI 30 FEMALE 39753 MS/MR MVR/ANNULOPLASTY MOD MILD
29 MURUGAN 22 MALE 30484 MS/MR MVR/ANNULOPLASTY SEVERE MILD
30 VIJAYA 28 FEMALE 57824 MS/MR MVR MILD MILD
31 REVATHI 26 FEMALE 64925 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
32 JAYANTHI 32 FEMALE 51812 CAMS MVR/DEVEGA MOD MILD
33 ARUMUGAM 30 MALE 58961 MS/LACLOT MVR/DEVEGA MOD MILD
34 JAYAMANI 28 FEMALE 52483 MS/MR MVR/DEVEGA MOD MILD
35 BAKKIYAM 40 FEMALE 56420 MS/LACLOT MVR MILD MILD
36 MUTHUSELVI 40 FEMALE 60024 MS/LACLOT MVR/DEVEGA MOD MILD
37 SAGAYAMARY 28 FEMALE 26592 MS/MR MVR/DEVEGA MOD MILD
38 MURUGAN 31 MALE 59916 MS/MR MVR/ANNULOPLASTY SEVERE MILD
39 MANIKAM 40 MALE 52435 CAMS MVR MILD MILD
40 SIVARAMAN 38 MALE 56226 CAMS MVR/DEVEGA MOD MILD
41 SELVARAJ 40 MALE 66417 MS/LACLOT MVR MILD MILD
42 VIJAYA 29 FEMALE 76689 MS/MR MVR/DEVEGA MOD MILD
43 AHAMED 25 FEMALE 66435 MS/MR MVR/DEVEGA MOD MILD
44 AMALRAJ 32 MALE 41315 MS/MR MVR/ANNULOPLASTY MOD MILD
45 BABU 38 MALE 58935 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
46 RAMYA 25 FEMALE 61951 MS/MR MVR MILD MILD
47 SAMUEL 32 MALE 62225 CAMS MVR/ANNULOPLASTY MOD MILD
48 MARIMUTHU 40 MALE 62805 CAMS MVR/DEVEGA MOD MILD
49 MATHU 40 MALE 62810 MS/MR MVR MILD MILD
50 VENUGOPAL 40 MALE 68448 MS/LACLOT MVR/DEVEGA SEVERE MILD
51 KANCHANA 25 FEMALE 30454 CAMS MVR/DEVEGA MOD MILD
52 ANITHA 30 FEMALE 71178 MS/MR MVR/DEVEGA MOD MILD
53 LAVANYA 30 FEMALE 68401 CAMS MVR MILD MILD
54 SELVI 37 FEMALE 63886 CAMS MVR/ANNULOPLASTY SEVERE MILD
55 SUMATHY 32 FEMALE 62751 MS/MR MVR/ANNULOPLASTY SEVERE MILD
56 ARJUNAN 38 MALE 52508 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
57 JAYAPERUMAL 29 MALE 65882 MS/MR MVR/ANNULOPLASTY SEVERE MILD
58 VADIVEL 38 MALE 63070 CAMS MVR/DEVEGA MOD MILD
59 PUSHPARANI 40 FEMALE 53743 CAMS MVR MILD MILD
60 MANIKAM 38 MALE 70751 MS/MR MVR/DEVEGA MOD MILD
61 BANU 30 FEMALE 74711 MS/MR MVR/DEVEGA MOD MILD
62 CHANDRAN 35 MALE 55149 CAMS MVR/ANNULOPLASTY SEVERE MILD
63 RAVI 40 MALE 64289 CAMS MVR MILD MILD
64 MARUTHAMAL 39 FEMALE 73259 MS/LACLOT MVR/ANNULOPLASTY MOD MILD
65 BABU 20 MALE 84840 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
66 RADHA 30 FEMALE 76626 MS/MR MVR/DEVEGA MOD MILD
67 ALAMELU 39 FEMALE 61968 CAMS MVR/ANNULOPLASTY SEVERE MILD
68 VALLI 34 FEMALE 74451 MS/LACLOT MVR/DEVEGA MOD MILD
69 MAHESWARI 32 FEMALE 73268 CAMS MVR MILD MILD
70 KUMUDHA 39 FEMALE 67407 MS/MR MVR/DEVEGA MOD MOD
71 RAMU 35 MALE 77264 MS/MR MVR/ANNULOPLASTY MOD MILD
72 mangai 37 FEMALE 76309 CAMS MVR/DEVEGA MOD MILD
73 BARATHI 35 FEMALE 62787 MS/MR MVR/ANNULOPLASTY MOD MILD
74 PERIYASAMY 40 MALE 52131 CAMS MVR/ANNULOPLASTY SEVERE MILD
75 NAGAMUTHU 40 FEMALE 85475 MS/LACLOT MVR MILD MILD
76 VIJAY 32 MALE 85258 MS/LACLOT MVR/DEVEGA MOD MILD
77 LALITHA 38 FEMALE 46308 MS/MR MVR/ANNULOPLASTY SEVERE MILD
78 KAVITHA 31 FEMALE 87438 MS/MR MVR/DEVEGA MOD MILD
79 ARUMUGHAM 38 MALE 88384 CAMS MVR/DEVEGA MOD MILD
80 LAXMI 34 FEMALE 80328 CAMS MVR MILD MILD
81 ESWARAN 33 MALE 88786 MS/MR MVR/DEVEGA MOD MILD
82 KOWSALYA 35 FEMALE 90641 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
83 VENKATESAN 38 MALE 83784 MS/MR MVR/DEVEGA MOD MILD
84 UMA 38 FEMALE 88929 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
85 NIRMALA 40 FEMALE 84023 MS/LACLOT MVR/DEVEGA MOD MILD
86 ANITHA 40 FEMALE 95238 MS/MR MVR/ANNULOPLASTY SEVERE MILD
87 MANJULA 35 FEMALE 91159 CAMS MVR MILD MILD
88 SHANMUGAM 40 MALE 91449 MS/MR MVR/ANNULOPLASTY MOD MILD
89 KAMARAJ 39 MALE 86156 CAMS MVR MILD MILD
90 SELVARANI 38 FEMALE 96726 CAMS MVR/DEVEGA MOD MILD
91 ELANGO 39 MALE 90868 MS/MR MVR/DEVEGA MOD MILD
92 JANAKI 40 FEMALE 84035 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
93 DAMODARAN 39 FEMALE 102219 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
94 SUNDARAM 40 FEMALE 101318 CAMS MVR/ANNULOPLASTY MOD MILD
95 KALPANA 29 FEMALE 94276 MS/MR MVR MILD MILD
96 NIRMALA 40 FEMALE 82702 MS/MR MVR/DEVEGA MOD MILD
97 RAMESH 34 MALE 99976 CAMS MVR/ANNULOPLASTY MOD MILD
98 ISMAIL 40 MALE 10061 MS/LACLOT MVR/DEVEGA MOD MILD
99 SUDHA 40 FEMALE 88726 MS/MR MVR MILD MILD
100 RAMU 40 MALE 18081 MS/MR MVR/ANNULOPLASTY MOD MILD
101 RANGASAMY 34 MALE 91476 CAMS MVR/ANNULOPLASTY MOD MILD
102 SURUMBAYEE 40 FEMALE 10315 MS/LACLOT MVR/ANNULOPLASTY MOD MILD
103 SEENIVASAN 39 MALE 35770 CAMS MVR/DEVEGA MOD MILD
104 ELUMALAI 40 MALE 97374 CAMS MVR/DEVEGA MOD MILD
105 DHANDAPANI 40 MALE 88091 MS/MR MVR/DEVEGA SEVERE MILD
106 SEKHAR 21 MALE 4713 MR(SEVERE) MVR MILD MILD
107 JOTHI 37 MALE 87719 MS/MR MVR/ANNULOPLASTY SEVERE MILD
108 SUGUNA 34 FEMALE 5647 MS/MR MVR/ANNULOPLASTY SEVERE MILD
109 GANDHI 33 MALE 5475 CAMS MVR/ANNULOPLASTY MOD MILD
110 MARY 30 FEMALE 8784 MS/LACLOT MVR/DEVEGA MOD MILD
111 PERUMAL 30 MALE 10188 CAMS MVR/ANNULOPLASTY SEVERE MILD
112 MOORTHY 27 MALE 8828 MS/MR MVR MOD MOD
113 MANONMANI 36 FEMALE 3576 MS/MR MVR/DEVEGA MOD MILD
114 PARAMESWARAN 38 MALE 29752 CAMS MVR/DEVEGA SEVERE MILD
115 SELVI 20 FEMALE 98702 MR(SEVERE) MVR/DEVEGA MOD MILD
116 RAVICHANDRAN 38 MALE 7957 MS/MR MVR/DEVEGA MOD MILD
117 THANGARAJ 22 MALE 8846 MS/LACLOT MVR/DEVEGA SEVERE MILD
118 KAMALA 40 FEMALE 10794 MS/MR MVR/ANNULOPLASTY SEVERE MILD
119 USHA 20 FEMALE 13648 CAMS MVR MILD MILD
120 MALATHY 32 FEMALE 94127 MS/MR MVR/DEVEGA MOD MILD
121 SHANTHI 37 FEMALE 7368 MS/MR MVR/ANNULOPLASTY SEVERE MILD
122 KASIAMMAL 38 FEMALE 100219 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
123 DARUNISHA 38 FEMALE 100219 MS/MR MVR/DEVEGA MOD MILD
124 VAITHYANATHAN 40 MALE 9415 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
125 KAMATCHI 34 FEMALE 97191 CAMS MVR/ANNULOPLASTY MOD MILD
126 GIRIJA 32 FEMALE 9431 MS/MR MVR/DEVEGA MOD MILD
127 INDHRA 25 FEMALE 14408 MR(SEVERE) MVR/ANNULOPLASTY MOD MILD
128 ILAYAPRIYA 26 FEMALE 9697 MS/MR MVR/DEVEGA MOD MILD
129 LAXMI 30 FEMALE 13969 CAMS MVR/DEVEGA MOD MILD
130 RAMACHANDRAN 20 MALE 13376 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
131 KARTHICK 23 MALE 7074 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MOD
132 MARIAPPAN 40 MALE 11491 MS/MR MVR/DEVEGA MOD MILD
133 NAGAMANI 22 FEMALE 9975 MS/MR MVR/ANNULOPLASTY MOD MILD
134 ANBUMANI 40 MALE 19831 CAMS MVR/DEVEGA SEVERE MILD
135 VAJRAVEL 40 MALE 5052 MS/LACLOT MVR/DEVEGA MOD MILD
136 CHINNATHAMBI 40 MALE 22859 MS/LACLOT MVR MILD MILD
137 MANIKANDAM 23 MALE 17214 MR(SEVERE) MVR/ANNULOPLASTY MOD MILD
138 LAXMI 29 FEMALE 10915 MS/MR MVR/DEVEGA MOD MILD
139 NALLATHANGAL 38 FEMALE 23135 MS/MR MVR MILD MILD
140 ARULRAJ 24 MALE 20211 MR(SEVERE) MVR/DEVEGA MOD MILD
141 DEVI 30 FEMALE 22867 CAMS MVR/DEVEGA MOD MILD
142 LALITHA 27 FEMALE 21740 MS/MR MVR/ANNULOPLASTY SEVERE MILD
143 PATCHAIAMMAL 40 FEMALE 26714 MS/MR MVR/ANNULOPLASTY SEVERE MOD
144 SIVAKUMAR 30 MALE 228149 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
145 JAYANTHI 25 FEMALE 28949 MR(SEVERE) MVR/DEVEGA MOD MILD
146 BAKYALAXMI 24 FEMALE 24238 MS/MR MVR/DEVEGA MOD MILD
147 KALAIARASI 27 FEMALE 25325 CAMS MVR/DEVEGA MOD MILD
148 MANJULA 38 FEMALE 10399 MS/LACLOT MVR/DEVEGA MOD MILD
149 SAKTHIVEL 25 MALE 28953 CAMS MVR/DEVEGA SEVERE MILD
150 VADIVEL 25 MALE 28081 MS/MR MVR MILD MILD
151 DURAISAMY 29 MALE 31984 CAMS MVR/ANNULOPLASTY SEVERE MILD
152 PERUMAL 22 MALE 32363 MS/MR MVR/DEVEGA MOD MILD
153 BAKIYANATHAN 35 MALE 29532 MS/LACLOT MVR/DEVEGA SEVERE MILD
154 RANI 30 FEMALE 27989 CAMS MVR/DEVEGA MOD MILD
155 PONMANI 40 FEMALE 12389 MS/LACLOT MVR/DEVEGA MOD MILD
156 MANDAPATHAL 28 FEMALE 30329 MS/MR MVR/DEVEGA MOD MILD
157 SELVARAJ 29 FEMALE 20222 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
158 NAGARAJ 29 MALE 32097 MS/MR MVR/DEVEGA MOD MILD
159 HARI 40 MALE 38344 CAMS MVR/DEVEGA MOD MILD
160 RATHI 39 FEMALE 33932 MS/LACLOT MVR/ANNULOPLASTY MOD MILD
161 TANTHONY 28 FEMALE 28434 CAMS MVR/ANNULOPLASTY SEVERE MILD
162 KUPPU 38 FEMALE 42840 MS/MR MVR/DEVEGA SEVERE MILD
163 PAPPAMAL 40 FEMALE 38937 CAMS MVR/ANNULOPLASTY SEVERE MILD
164 MALATHY 34 FEMALE 30022 MS/LACLOT MVR MOD MOD
165 KARTHIKEYAN 36 MALE 35216 MS/MR MVR/DEVEGA MOD MILD
166 BASKHAR 40 MALE 45512 MS/MR MVR/ANNULOPLASTY SEVERE MILD
167 GEETHA 32 FEMALE 42115 CAMS MVR/DEVEGA MOD MILD
168 KARPAGAM 35 FEMALE 34954 MS/LACLOT MVR/DEVEGA MOD MILD
169 VIJAYAKUMAR 29 MALE 24462 CAMS MVR/DEVEGA MOD MILD
170 KALIAMMAL 40 FEMALE 44129 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
171 JAYA 37 FEMALE 42462 MS/MR MVR/DEVEGA MOD MILD
172 KASINATHAN 35 MALE 51243 CAMS MVR/DEVEGA MOD MILD
173 JAYANTHI 36 FEMALE 51238 MS/LACLOT MVR/DEVEGA MOD MILD
174 PRABHAKARAN 22 MALE 52246 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
175 MONA 40 FEMALE 49468 MS/MR MVR/ANNULOPLASTY MOD MILD
176 AMBIKA 39 FEMALE 45151 MS/LACLOT MVR/DEVEGA MOD MILD
177 LAXMI 32 FEMALE 46167 CAMS MVR/DEVEGA SEVERE MILD
178 JOTHI 38 FEMALE 59071 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
179 ANJALI 30 FEMALE 50571 MS/MR MVR/DEVEGA MOD MILD
180 SARALA 25 FEMALE 56491 MS/LACLOT MVR MILD MILD
181 UMAPATHY 34 MALE 58370 MS/LACLOT MVR/ANNULOPLASTY MOD MILD
182 SOUNDARAJAN 33 MALE 55629 MS/MR MVR MILD MILD
183 SHANKAR 38 MALE 54088 MR(SEVERE) MVR/DEVEGA SEVERE MILD
184 RAJA 35 MALE 62585 MS/MR MVR/DEVEGA MOD MILD
185 VALLI 33 FEMALE 70389 MS/MR MVR/DEVEGA SEVERE MILD
186 UMA 28 FEMALE 70397 MS/MR MVR/ANNULOPLASTY MOD MILD
187 KAVITHA 24 FEMALE 72222 MS/LACLOT MVR/DEVEGA MOD MILD
188 MURUGAN 28 MALE 35540 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
189 VADIVEL 36 MALE 67894 MS/MR MVR/DEVEGA MOD MILD
190 JAYANYHI 27 FEMALE 67385 MR(SEVERE) MVR/DEVEGA SEVERE MILD
191 LATHA 30 FEMALE 54867 MS/MR MVR/ANNULOPLASTY MOD MILD
192 PADMANABAN 34 MALE 78114 MS/LACLOT MVR/ANNULOPLASTY MOD MILD
193 MAHALAXMI 38 FEMALE 69311 MS/MR MVR/DEVEGA MOD MILD
194 ANGAMAL 39 FEMALE 68868 MS/MR MVR/DEVEGA MOD MILD
195 SUMATHY 38 FEMALE 61314 MS/MR MVR/DEVEGA MOD MILD
196 VETRI 26 MALE 72238 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
197 PARAVATHY 40 FEMALE 77954 CAMS MVR/DEVEGA MOD MILD
198 VANDI 26 MALE 74394 CAMS MVR/ANNULOPLASTY SEVERE MILD
199 PARIMALA 40 FEMALE 79750 MS/MR MVR/DEVEGA SEVERE MILD
200 RATHNAM 34 FEMALE 75841 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
201 SARATHA 40 FEMALE 74070 MS/MR MVR/ANNULOPLASTY MOD MILD
202 YESUPADHAM 35 MALE 67749 CAMS MVR/DEVEGA MOD MILD
203 SRIDEVI 20 FEMALE 76336 MR(SEVERE) MVR/ANNULOPLASTY MOD MILD
204 MANI 40 MALE 79808 CAMS MVR/DEVEGA MOD MILD
205 RADHA 37 FEMALE 79347 MS/MR MVR/ANNULOPLASTY SEVERE MILD
206 RATHNAM 40 FEMALE 61289 MS/MR MVR/DEVEGA MOD MILD
207 MALAR 38 FEMALE 71136 MS/LACLOT MVR/DEVEGA MOD MILD
208 RADHA 37 FEMALE 79347 CAMS MVR/ANNULOPLASTY SEVERE MILD
209 JOTHI 38 FEMALE 72922 MS/MR MVR MILD MILD
210 RAJKUMAR 27 MALE 67590 MS/MR MVR/DEVEGA MOD MILD
211 HARIDOSS 36 MALE 71601 MS/MR MVR/DEVEGA SEVERE MILD
212 VADIVEL 30 MALE 76350 CAMS MVR/DEVEGA SEVERE MILD
213 KRISHNAN 38 MALE 62732 MS/MR MVR MILD MILD
214 LALITHA 33 FEMALE 80719 MS/MR MVR/ANNULOPLASTY SEVERE MILD
215 SATISH 23 MALE 74345 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
216 VALI 33 FEMALE 81986 CAMS MVR MILD MILD
217 CHITRA 30 FEMALE 74686 MS/LACLOT MVR/ANNULOPLASTY SEVERE MILD
218 ELLAMAL 40 FEMALE 60527 CAMS MVR/DEVEGA MOD MILD
219 SAKTHIVEL 17 MALE 88445 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
220 ARUNA 40 FEMALE 65344 MS/MR MVR/ANNULOPLASTY MOD MILD
221 DHANALAXMI 40 FEMALE 80760 CAMS MVR/ANNULOPLASTY SEVERE MILD
222 SELVI 37 FEMALE 78880 MS/MR MVR/DEVEGA MOD MILD
223 SUMATHY 29 FEMALE 86514 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
224 SATHYA 24 FEMALE 98912 MS/MR MVR MILD MILD
225 VIMALATHA 23 FEMALE 79781 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
226 BASKAR 40 MALE 78787 MS/MR MVR/DEVEGA MOD MILD
227 KULLAMAL 32 FEMALE 48639 CAMS MVR/DEVEGA MOD MILD
228 MADHURAM 40 FEMALE 51916 MS/MR MVR/DEVEGA SEVERE MILD
229 SARALA 38 FEMALE 34667 MS/LACLOT MVR/DEVEGA SEVERE MILD
230 CHANDRAN 40 MALE 56102 MS/LACLOT MVR MILD MILD
231 SARAVANAN 35 MALE 55127 CAMS MVR/ANNULOPLASTY SEVERE MILD
232 VELAYUTHAM 40 MALE 53128 MS/MR MVR/ANNULOPLASTY SEVERE MILD
233 MARY 36 FEMALE 48565 MS/LACLOT MVR/DEVEGA MOD MILD
234 SEENIVASAN 39 MALE 52341 MS/MR MVR/ANNULOPLASTY SEVERE MILD
235 RANI 40 FEMALE 45181 MS/LACLOT MVR/DEVEGA MOD MILD
236 ELLAMAL 40 FEMALE 47284 MS/MR MVR MILD MILD
237 SARADHA 38 FEMALE 44893 CAMS MVR/DEVEGA SEVERE MILD
238 SUBRAMANI 40 FEMALE 47505 CAMS MVR/ANNULOPLASTY SEVERE MILD
239 VIJAYAN 39 MALE 51628 MS/MR MVR/DEVEGA MOD MILD
240 SARALA 30 FEMALE 47340 MS/LACLOT MVR/ANNULOPLASTY MOD MILD
241 DRAUPATHY 29 FEMALE 63771 MR(SEVERE) MVR/DEVEGA MOD MILD
242 KUPPAMAL 30 FEMALE 53373 MR(SEVERE) MVR/ANNULOPLASTY MOD MILD
243 NITHYA 20 FEMALE 60550 CAMS MVR/ANNULOPLASTY SEVERE MILD
244 RAJATHI 40 FEMALE 49592 CAMS MVR/DEVEGA MOD MILD
245 MALIK 40 MALE 59394 MS/MR MVR MOD MOD
246 SELVI 20 FEMALE 62623 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
247 RAJESWARI 35 FEMALE 62679 MS/MR MVR/DEVEGA SEVERE MILD
248 SARAVANAN 20 MALE 54426 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
249 ANBARASAN 20 MALE 81265 MR(SEVERE) MVR/ANNULOPLASTY SEVERE MILD
250 RAVI 23 MALE 81287 MS/MR MVR/ANNULOPLASTY SEVERE MILD
